Medical Condition News

RSS

FDA grants CSL Behring marketing approval for Corifact in treatment of congenital FXIII deficiency

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Corifact™, Factor XIII Concentrate (Human), for the routine prophylactic treatment of congenital factor XIII (FXIII) deficiency. Corifact, already available for use in 12 countries throughout the world under the trade name Fibrogammin®- P, is the first and only FXIII concentrate approved in the U.S.

19 Feb 2011

ADAO applauds U.S. Senate for introduction of resolution recognizing National Asbestos Awareness Week

The Asbestos Disease Awareness Organization, combining education, advocacy and community as the largest U.S. organization serving as the voice of asbestos victims, today applauds Senator Max Baucus and cosponsors for introducing a resolution that declares the first week of April as "National Asbestos Awareness Week" and seeks to "raise public awareness about the prevalence of asbestos-related diseases and the dangers of asbestos exposure."

19 Feb 2011

American Cancer Society receives AAHPM Presidential Citation Award for palliative care research

The American Cancer Society has been selected to receive a Presidential Citation Award from American Academy of Hospice and Palliative Medicine recognizing the Society's commitment to support research to address quality of life issues and to promote patient-centered care.

19 Feb 2011

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

A new study has identified factors that predict the ability of a professional dancer to return to professional performance after hip arthroscopy surgery. The study by Hospital for Special Surgery investigators will be presented at the American Academy of Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San Diego, Calif.

19 Feb 2011

Deep brain stimulation therapy promising against severe OCD

When obsessive-compulsive disorder is of crippling severity and drugs and behavior therapy can't help, there has been for just over a year a thread - or rather a wire - of hope. By inserting a thin electrode deep into the brain, doctors can precisely deliver an electrical current to a cord of the brain's wiring and soften the severity of the symptoms. "Deep brain stimulation" therapy for OCD won Food and Drug Administration approval in 2009 for extreme cases under its humanitarian device exemption.

19 Feb 2011

Canadian Cancer Society praises new, enhanced cigarette package warnings

Today, Health Canada released a set of new picture health warnings for cigarette and little cigar packages. The new labels include 16 warnings that will cover 75 per cent of the package front and back, eight additional messages to be printed inside the package (or on an insert), and four toxic emission messages for the side panel.

19 Feb 2011

New research: Incidence of PE after knee arthroscopy is 0.028%

Until now, the risk of pulmonary embolism after a knee arthroscopy has not been accurately defined and risk factors have only been suggested but not proven. New research, presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons shows that the incidence of symptomatic PE after outpatient knee arthroscopy is .028 percent.

19 Feb 2011

Hamstring tendon graft may be better than knee graft for ACL knee reconstruction: Study

Patients receiving anterior cruciate ligament (ACL) knee reconstruction with a hamstring tendon graft rather than a knee tendon graft were less likely to suffer from pain and mobility issues15 years after surgery, say researchers presenting a study today at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Diego, California (February 19).

19 Feb 2011

Positive results from Medtronic CoreValve System study for treatment of aortic valve disease

Medtronic, Inc. today issued a statement on results from an independent study published online in the journal Circulation, which confirmed both early and sustained clinical benefits for patients receiving the Medtronic CoreValve® System for the treatment of aortic valve disease.

19 Feb 2011

Positive outcomes from first surgery using Zimmer's DeNovo NT Graft for repair of cartilage lesions

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced that results from a peer-reviewed publication demonstrated positive outcomes from the first surgery performed using the DeNovo NT Graft for the repair of cartilage lesions.

19 Feb 2011

Therapeutic hypothermia after resuscitation from cardiac arrest improves survival and functional status

Mayo Clinic researchers confirmed that patients who receive therapeutic hypothermia after resuscitation from cardiac arrest have favorable chances of surviving the event and recovering good functional status.

19 Feb 2011

Smith & Nephew introduces Short Modular Femoral Hip System for orthopaedic surgery

At this week's annual meeting of the American Academy of Orthopedic Surgeons, Smith & Nephew Orthopaedic Division introduced its Short Modular Femoral Hip System, a modular total hip replacement stem system that exceeds the versatility and neck strength of a standard, full-size primary hip stem, while providing the stability of the traditionally longer, more invasive implant.

19 Feb 2011

Research suggests weight loss greatly improves knee pain related to OA

Knee pain related to osteoarthritis is a common complaint among obese individuals and retired professional athletes, especially former NFL players, but researchers presenting their work at the American Orthopaedic Society for Sports Medicine's Specialty Day program say they have a simple solution: lose weight.

19 Feb 2011

Redsense safety device receives 8 hour FDA clinical clearance for nocturnal dialysis

The Redsense safety device is the only device cleared by FDA to monitor patients for potential blood loss from the hemodialysis needle puncture site. With an 8 hour FDA clinical clearance, Redsense is available to help protect patients undergoing treatment in clinics for longer than 5 hours - such as Nocturnal Dialysis.

19 Feb 2011

FDA clears Zimmer TM-S Trabecular Metal Cervical Interbody Fusion Device

Zimmer Holdings, a leader in musculoskeletal care, today announced it has received FDA clearance for the TM-S Trabecular Metal Cervical Interbody Fusion Device.

19 Feb 2011

ASU, CGU enter agreement to establish international Biosignatures Center

Arizona State University and Taiwan's Chang Gung University have formalized an agreement to establish an international Biosignatures Center aimed at the prevention, early detection, diagnosis, and treatment of cancer and other diseases.

19 Feb 2011

Texas Children's scientist receives CAREER Award for congenital heart research

Texas Children's Hospital in Houston announces that a researcher in its Pediatric Cardiac Bioengineering Laboratory has earned a National Science Foundation Early Career Development Award for his work in studying the causes of congenital heart disease, heart defects, and the development of tissue engineering therapies using stem cells derived from human amniotic fluid.

19 Feb 2011

Doctor explores link between lack of oxygen and inflammation in patients undergoing surgery

When the body is deprived of oxygen during a major surgery, the kidneys, heart muscles or lungs can be injured as a result. The problem is that lack of oxygen can lead to inflammation.

19 Feb 2011

Scientists discover evidence linking brain function variations to birth size, weight of placenta

Scientists have discovered the first evidence linking brain function variations between the left and right sides of the brain to size at birth and the weight of the placenta. The finding could shed new light on the causes of mental health problems in later life.

18 Feb 2011

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has signed a licensing agreement with Biocare Medical, a biotechnology company based in Concord, Calif., for the exclusive worldwide sales and distribution rights for the immunohistochemistry of an antibody designed to detect tumor prevalence in prostate cancer patients.

18 Feb 2011

Medical Condition News

FDA grants CSL Behring marketing approval for Corifact in treatment of congenital FXIII deficiency

ADAO applauds U.S. Senate for introduction of resolution recognizing National Asbestos Awareness Week

American Cancer Society receives AAHPM Presidential Citation Award for palliative care research

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

Deep brain stimulation therapy promising against severe OCD

Canadian Cancer Society praises new, enhanced cigarette package warnings

New research: Incidence of PE after knee arthroscopy is 0.028%

Hamstring tendon graft may be better than knee graft for ACL knee reconstruction: Study

Positive results from Medtronic CoreValve System study for treatment of aortic valve disease

Positive outcomes from first surgery using Zimmer's DeNovo NT Graft for repair of cartilage lesions

Therapeutic hypothermia after resuscitation from cardiac arrest improves survival and functional status

Smith & Nephew introduces Short Modular Femoral Hip System for orthopaedic surgery

Research suggests weight loss greatly improves knee pain related to OA

Redsense safety device receives 8 hour FDA clinical clearance for nocturnal dialysis

FDA clears Zimmer TM-S Trabecular Metal Cervical Interbody Fusion Device

ASU, CGU enter agreement to establish international Biosignatures Center

Texas Children's scientist receives CAREER Award for congenital heart research

Doctor explores link between lack of oxygen and inflammation in patients undergoing surgery

Scientists discover evidence linking brain function variations to birth size, weight of placenta

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Latest News